Sign inJoin
Search

Find research, discussions, posts, companies, and topics.

Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.

1Results1Tickers
Reset
Selected tags
CannabisINCZiprecruiterZEDGE
Clear tags
MatchAny tagAll tags
Refine results

Recent Searches

Signed-in searches appear here after you use search.

Trending

XORTX Therapeutics Inc.: the filing proof gates that matter nowWilliams Companies: natural-gas infrastructure cash flow has to outlast capex and rate riskAurora Cannabis (ACB): the medical-cannabis turnaround trying to outrun dilutionAbbVie Inc. (ABBV) Coverage Bootstrap: Skyrizi and Rinvoq-led biopharma transition after HumiraAmbev (ABEV) Coverage Bootstrap: beer-led scale, Brazil execution, pricing discipline, and cash returnsAsbury Automotive Group (ABG) Coverage Bootstrap: dealership scale, service profit, F&I scrutiny, and leverage disciplineAble View Global (ABLV) Coverage Bootstrap: China beauty brand management, channel concentration, controlled voting, and listing riskABM Industries (ABM) Coverage Bootstrap: facility services scale, margin recovery, WGNSTAR integration, and labor execution

Top Tickers

ACB1

Popular Tags

Cannabis1Consumer Staples1Coverage Bootstrap1Medical Cannabis1Turnaround1
Results

Latest indexed results

Showing public results only.

Save search
ArticlefinanceACB

Aurora Cannabis (ACB): the medical-cannabis turnaround trying to outrun dilution

Aurora is trying to leave the worst cannabis-stock habits behind: Q3 FY2026 medical cannabis revenue set a record, management is exiting weaker Canadian consumer lanes, and the balance sheet has cash. The catch is that IFRS losses, Bevo restructuring, internal-control weaknesses, and an open ATM keep the turnaround on probation.

May 13, 2026public
Coverage BootstrapCannabisMedical CannabisTurnaroundConsumer Staples
Open